Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III study of H062 tablets in primary hypertension inadequately controlled by amlodipine monotherapy
CTR20252089Phase 3Active
- Sponsor
- Shanghai Huilun Pharmaceutical Co., Ltd.
- Start
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Levamlodipine in essential hypertension, sponsored by Shanghai Huilun Pharmaceutical Co., Ltd.. Started Aug 2025; status: active.
02
Drugs
Levamlodipine
03
Conditions
essential hypertension
Beyond the preview
Go deeper on CTR20252089.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20252089.